首页> 美国卫生研究院文献>California Medicine >Blue-Yellow Vision Deficits in Patients With Diabetes
【2h】

Blue-Yellow Vision Deficits in Patients With Diabetes

机译:糖尿病患者的蓝黄色视力障碍

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Home blood glucose monitoring has been introduced as a means to achieve good control in patients with diabetes mellitus. Many patients use color-reagent strips and color comparisons to determine blood glucose levels. Intact color vision in the blue-yellow range is necessary for accurately interpreting these strips.Blue-yellow vision deficits occur as a consequence of eye disease and are not genetic or sex-linked. We evaluated blue-yellow vision acuity in 70 diabetic patients and in 19 age-matched control subjects. The patients with diabetes were subdivided according to their degree of retinopathy as follows: no disease (N = 14), nonproliferative diabetic retinopathy (N = 16), proliferative diabetic retinopathy (N = 14) and postlaser-treated (N = 26). None of the control group had deficits. Each group of diabetic patients had a statistically significant increase in color vision deficits compared with the controls. In the laser-treated group, deficits occurred in most patients, were more severe and were significantly increased over all other diabetic subgroups. These deficits may impair visual interpretation of home blood glucose monitoring strips.
机译:引入家庭血糖监测作为对糖尿病患者实现良好控制的一种手段。许多患者使用显色试剂条和颜色比较来确定血糖水平。蓝黄色范围内完整的彩色视觉对于准确地解释这些条带是必不可少的。蓝黄色视觉缺陷是由眼疾引起的,并且与遗传或性别无关。我们评估了70位糖尿病患者和19位年龄匹配的对照受试者的蓝黄色视力。糖尿病患者根据其视网膜病变程度分为以下几类:无疾病(N = 14),非增生性糖尿病视网膜病变(N = 16),增生性糖尿病视网膜病变(N = 14)和激光治疗后(N = 26)。对照组均无赤字。与对照组相比,每组糖尿病患者的色觉缺陷都有统计学上的显着增加。在激光治疗组中,与所有其他糖尿病亚组相比,大多数患者出现缺陷,更为严重,并且明显增加。这些缺陷可能会损害家用血糖监测条的视觉解释。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号